Patient‐Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019

The measurement and analysis of patient‐reported outcomes is important in cancer clinical trials. This commentary reports advances and challenges from presentations at the 2019 Accelerating Anticancer Agent Development and Validation (AAADV) Workshop Patient‐Reported Outcomes Session.

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Bhatnagar, Vishal, Hudgens, Stacie, Piault‐Louis, Elisabeth, Jones, Lee, Beaver, Julia A., Lyerly, H. Kim, Reaman, Gregory, Fleming, Thomas, Kluetz, Paul G.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2020
Assuntos:
Commentaries
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543246/
https://ncbi.nlm.nih.gov/pubmed/32463153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0062
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares